In Vitro antioxidant Activity of Ethanolic Extract of Chlorophytum Borivilianum
Its dosed weekly and used primarily for managing Type 2 diabetes, although its often prescribed off-label for weight loss. Wegovy costs around $1,300 per package out-of-pocket
TDN, in particular, may represent a complementary anti-obesity or anti-diabetes agent with the benefits of weight and glucose control, but without the gastrointestinal side effects that often limit GLP-1 therapies
Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study
The meta-analysis of the ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony, PIONEER 6, REWIND and AMPLITUDE-O trials shows that the extent of HbA 1c reduction may serve as a proxy for the renal benefits of GLP-1RA therapy